| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WEX | Common Stock | Options Exercise | $868,599 | +8,713 | +84% | $99.69 | 19,071 | 14 Feb 2023 | Direct | |
| transaction | WEX | Common Stock | Options Exercise | $73,885 | +704 | +3.7% | $104.95 | 19,775 | 14 Feb 2023 | Direct | |
| transaction | WEX | Common Stock | Options Exercise | $353,325 | +3,222 | +16% | $109.66 | 22,997 | 14 Feb 2023 | Direct | |
| transaction | WEX | Common Stock | Sale | $3,277,883 | -16,639 | -72% | $197.00 | 6,358 | 14 Feb 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WEX | Stock Option (right to buy) | Options Exercise | $0 | -8,713 | -100% | $0.000000* | 0 | 14 Feb 2023 | Common Stock | 8,713 | $99.69 | Direct | F1 |
| transaction | WEX | Stock Option (right to buy) | Options Exercise | $0 | -704 | -100% | $0.000000* | 0 | 14 Feb 2023 | Common Stock | 704 | $104.95 | Direct | |
| transaction | WEX | Stock Option (right to buy) | Options Exercise | $0 | -3,222 | -67% | $0.000000 | 1,617 | 14 Feb 2023 | Common Stock | 3,222 | $109.66 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Half of the performance based non-statutory stock options ("Performance-Based NSOs"), reported on the Reporting Person's Form 4 dated May 12, 2017 (the "Original Form 4"), vested on June 26, 2020 when the Company's closing stock price was at least $149.54 for twenty consecutive trading days. Another quarter of the Performance-Based NSOs vested on December 29, 2020 when the Company's closing stock price was at least $174.45 for twenty consecutive trading days. The last remaining quarter of the Performance-Based NSOs vested on March 8, 2021 when the Company's closing stock price was at least $199.38 for twenty consecutive trading days. Please reference the Original Form 4 for further information regarding the vesting of the Performance-Based NSOs. |
| F2 | This stock option will vest with respect to the remaining one-third of these shares on 3/16/2023. |